Vaccine Status in Japan
Daiichi Sankyo announced yesterday (march 10) that the COVID-19 Vaccine they are developing with University of Tokyo will enter into special examination within this month.
Age 20 to 75 will be part of this study.
Daiichi Sankyo and University of Tokyo COVID-19 Vaccine will be the third (among 4) vaccine to be developed in Japan.
Source: Yomiuri Shimbun
Comments
Post a Comment